Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA-PK controls Apollo's access to leading-end telomeres. | Nucleic Acids Res | 2024 | 38407308 | PubTator, text mining | PubMed |
| Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer. | Front Oncol | 2024 | 38380364 | PubTator, text mining | PubMed |
| HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process. | Sci Rep | 2024 | 38365849 | PubTator, text mining | PubMed |
| Expanding the phenotypic spectrum of LIG4 pathogenic variations: neuro-histopathological description of 4 fetuses with stenosis of the aqueduct. | Eur J Hum Genet | 2024 | 38351293 | PubTator, text mining | PubMed |
| Structural role for DNA Ligase IV in promoting the fidelity of non-homologous end joining. | Nat Commun | 2024 | 38341432 | PubTator, text mining | PubMed |
| The fragile X locus is prone to spontaneous DNA damage that is preferentially repaired by nonhomologous end-joining to preserve genome integrity. | iScience | 2024 | 38303711 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a Mutagenic Factor. | Int J Mol Sci | 2024 | 38255897 | PubTator, text mining | PubMed |
| Established and Evolving Roles of the Multifunctional Non-POU Domain-Containing Octamer-Binding Protein (NonO) and Splicing Factor Proline- and Glutamine-Rich (SFPQ). | J Dev Biol | 2024 | 38248868 | PubTator, text mining | PubMed |
| Artemis as Predictive Biomarker of Responsiveness to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer. | Curr Oncol | 2024 | 38248122 | PubTator, text mining | PubMed |
| The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway. | Cell Death Dis | 2024 | 38238314 | PubTator, text mining | PubMed |
| ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines. | Oncotarget | 2024 | 38227740 | PubTator, text mining | PubMed |
| Molecular cloning, subcellular localization, and rapid recruitment to DNA damage sites of chicken Ku70. | Sci Rep | 2024 | 38216643 | PubTator, text mining | PubMed |
| SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair. | Oncogenesis | 2024 | 38191478 | PubTator, text mining | PubMed |
| Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor. | Cell Rep Med | 2024 | 38183981 | PubTator, text mining | PubMed |
| ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. | Theranostics | 2024 | 38169509 | PubTator, text mining | PubMed |
| Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening. | J Clin Immunol | 2024 | 38165471 | PubTator, text mining | PubMed |
| The Contribution of DNA Ligase 4 Polymorphisms to Colorectal Cancer. | In Vivo | 2024 | 38148049 | PubTator, text mining | PubMed |
| Phase separation in DNA double-strand break response. | Nucleus | 2024 | 38146123 | PubTator, text mining | PubMed |
| Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells. | Nucleic Acids Res | 2024 | 38109306 | PubTator, text mining | PubMed |
| The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells. | Nat Genet | 2024 | 38036782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=6